ClinicalTrials.gg
RecruitingNCT06976801Updated Jul 9, 2026

Tibial IMN Vs. Tibial Micromotion IMN

An interventional study of Intramedullary tibial Nail and Intermedullary nail in Tibial Fracture, sponsored by University of Chicago. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-09.

Sponsored by University of Chicago · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jul 2025; still recruiting 1 year 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
372
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 50 studies in Tibial Fractures with a site in United States — 15 open to participants now, 18 under way, 3 of them phase 3. Tibial Fractures · United States.

Planned enrollment
5th of 38
372 · median 53
Started
2025
with 3 others
No phase
27 of 50
10 open now
Primary completion
2029-12
later than 17 of 17 live
Registered
47th of 50
by date

Among the 50 studies in Tibial Fractures with a site in United States, this one is the 5th largest by planned enrollment of the 38 interventional ones that give a count, is one of 4 that started in 2025, is one of 27 with no phase, reaches primary completion later than 17 of the 17 other live ones, and was the 47th registered.

Tibial Fractures

136 studies on the registry are indexed under Tibial Fractures; 38 are open to participants now.

Browse Tibial Fractures studies →

Open to participants now

15 of the 50 studies in Tibial Fractures with a site in United States are open now. Recruiting first, the newest first:

9 more — sign in →

All 15 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 27 Tibial Fractures studies recruiting now, 13 (48%) set no upper age limit and 7 (26%) stop at 75 or younger; 5 take children under 18; 4 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 50 studies in Tibial Fractures with a site in United States, or all of them as a file.
02

Study summary

Our null hypothesis is that micromotion tibial intramedullary fixation (IMFN) does not impact union or complication rates when compared to standard of care treatment with non-micromotion tibial nail fixation. There are no current or past randomized controlled trials comparing these fixation techniques to one another. There is good data supporting both the use of intramedullary fixation for tibial fractures alone, and in high-risk patient populations (open fractures, GSW tibial fractures). However, the effectiveness of these methods with respect to each other has never been investigated. The knowledge gained will allow us to potentially influence and adapt protocols to treat this patient population. Additionally, resources available at our institution provide a supportive framework with which to maintain contact with patients after hospital discharge. These key factors will allow us to perform a robust analysis of this population, to include outcomes measures of function and complications.

With much of the limited existing literature on tibial nails being in very defined populations, without a strong comparison group there is no clear guidance on when the use of a micromotion device is indicated. Our approach to randomize our patients will reduce the bias that exists in the current literature and provide a robust spectrum of injuries to sub analyze and compare.

Objectives Primary Objective Compare post-operative union rates in tibial shaft patients treated with 2 types of intramedullary rod fixation devices.

Secondary Objective(s) Compare complication rates, patient reported outcomes, range of motion, pain and radiographic/sonographic outcomes in patients treated with tibial nails.

Read the detailed description

The advent of the intramedullary nail (IMN) has revolutionized the treatment of tibial shaft fractures due to its percutaneous route of insertion, frequent facilitation of immediate weightbearing, and high rate of union. Recent research has revealed that selection of an appropriate IMN diameter is vital for maintaining fracture reduction and preventing complications. Using a larger diameter nail increases construct stability, permits load-sharing, and may lead to higher rates of union. On the other hand, aggressive reaming to permit a larger nail diameter can result in iatrogenic fracture upon insertion or removal.

Modern tibial nail designs have remained largely unchanged in the last 20 years with small ergonomic and efficiency changes without large scale improvements in their biomechanical induction of bone healing at the fracture site. Traditionally they include distal locking screws as well as proximal locking screws that are either fixed or dynamic allowing for small but largely irrelevant amounts of motion. Our understanding of bone healing and indirect bone generation includes the concept of micromotion which induces the creation of fibrous followed by bony callus. This concept requires strain levels and adequate micromotion at fracture sites to be biomechanically advantageous. One new tibial nail device recently available in the US and FDA approved for tibial nail fixation hopes to improve the biomechanical and biology environment for tibial healing, the OrthoXel tibial nail system. Unfortunately, there is a paucity of strong clinical data to support it. Additionally, there have been no prospective, randomized studies investigating the used of this nail compared to standard tibial nail designs and no studies have evaluated it in high risk tibial non-union patients..

The primary purpose of this study is to perform a high-quality randomized control trial comparing intramedullary tibial nail fixation with standard design nails compared to a micromotion tibial nail device to evaluate the rates of union and post-operative outcomes. In an evaluation of patient factors, fracture patterns and patient reported outcomes, the investigators will bring clarity to the question of indications for the micromotion tibial nail in standard and high risk patients. To characterize our patient population, the investigators will evaluate type of injury (closed, open, gunshot wound), fracture morphology (OTA classification), patient risk factors (age, isolated vs. poly-trauma, Comorbidities, smoking, and Vit D levels) and surgical outcomes (blood loss, surgical time, construct stability). In addition to objective radiographic, ultrasonographic and physical exam outcomes, the investigators will collect patient reported outcomes in the form of PROMIS CAT and VAS scores.

Given the existing limitations in the literature, there is no guidance on indications for use of micromotion tibial nail fixation (MMIMNF) compared to standard intramedullary nail fixation (IMNF). By taking an approach that will be prospective and randomized, while assessing all known risk factors, the investigators expect our results will guide surgical treatment decisions around the use of these devices and in which populations they may be most useful. .

The proposed trial will be a parallel-group, superiority trial with equal randomization enrolling 242 tibial nail patients. Patients will be categorized into 2 cohorts: IMNF fixation(cohort 1), and MicroMotion Intramedullary tibial Nail fixation (cohort 2). The primary outcome will be nonunion. Secondary outcomes will include: overall complications (as a composite result (Infection ((deep and superficial)), revision surgery rate, removal of metalwork, non-union, malunion, amputation and death). Patient-Reported Outcomes Measurement Information System Physical Function Computerized Adaptive Testing (PROMIS PT CAT) scores, range of motion (ROM), pain, radiographic outcomes, time to bridging callus based on mRUST (>11) on Xray, time to single leg stance, and degree of callus seen on ultrasound at 6 \& 12 weeks.

03

Conditions studied

  • Tibial Fracture

Browse trials for

Keywords

  • Unstable tibial fracture
  • intramedullary nail
  • micromotion tibial nail fixation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 18 or older
  2. Unstable tibial fracture recommended for surgical intervention

Exclusion criteria

Exclusion Criteria:

  1. Patients not meeting inclusion criteria (Stable fracture patterns)
  2. Previously non-ambulatory patients
  3. Delayed presentation of fracture (>4 weeks)
  4. Fractures that the treating surgeon indicates requires additional fixation strategies to achieve stability
  5. Patients with an active infection or wound at the surgical site
  6. Utilizing worker's compensation at the time of screening
  7. Any previous ligament or fracture surgery on the index site
  8. Inflammatory rheumatic disease or other rheumatic disease
  9. Immune compromised patients (hepatitis, , etc.)
  10. Non-English-speaking patients
  11. Unwilling or unable to participate or follow study protocol
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
372 participants (estimated)

Study arms

  • Experimental
    micromotion tibial intramedullary fixation

    Subject will receive micromotion tibial intramedullary fixation

    Device: Intramedullary tibial Nail

  • Active comparator
    non-micromotion tibial nail fixation

    Subject will receive non-micromotion tibial nail fixation

    Device: Intermedullary nail

Interventions

  • DeviceIntramedullary tibial Nail

    Subjects will receive the micromotion MicroMotion Intramedullary tibial Nail

    Also known as: MicroMotion Intramedullary tibial Nail

  • DeviceIntermedullary nail

    The non-micromotion intermedullary nail

06

What researchers measure

Primary outcomes

  1. Compare post-operative union rates

    Compare post-operative union rates in tibial shaft patients treated with 2 types of intramedullary rod fixation devices.

    Time frame: six months

Secondary outcomes

  1. Compare complication rates

    Compare complication rates outcomes in patients treated with tibial nails

    Time frame: one year

  2. Time to single leg stance

    Time (in days) it takes for the subject stand on a single leg.

    Time frame: one year

  3. Any difference in patient reported outcomes scores physical function

    Patient Reported outcome scores physical function scores are reported on a T-score scale that ranges from 20-80, with higher scores indicating greater physical function.

    Time frame: one year

  4. Any difference in patient reported outcomes scores pain interference

    Patient Reported outcome scores pain interference scores are reported on a T-score scale that ranges from 6-30, with higher scores indicating greater physical function.

    Time frame: one year

  5. Ultra sound callus

    Checking if a callus has appeared

    Time frame: 6 weeks

  6. Ultra sound callus

    Checking if callus has appeared

    Time frame: 12 weeks

  7. Visual analog pain scale score

    Visual analog pain scale scores for the subject. Scored on a scale of 0 - 10. 0 no pain and 10 worst pain.

    Time frame: one year

Other outcomes

  1. Smoking Status

    Comparing the smoking status (yes/no and pack years) and return to OR timelines

    Time frame: one year

  2. Visual analog pain scale score

    Visual analog pain scale score? 0 (no pain) - 10 (worst pain)

    Time frame: one year

  3. Fixation failure rate

    Comparing the fixation failure rates between the two groups and return to OR timelines

    Time frame: one year

  4. Radiographic Mal-union

    Comparing Radiographic Mal-union rates between groups

    Time frame: one year

  5. Radiographic Non-union

    Comparing rates Radiographic Non-union between groups

    Time frame: one year

  6. Any difference in Patient reported outcomes scores depression

    Patient Reported outcome scores depression scores are reported on a T-score scale that ranges from 8 - 40, with higher scores indicating greater depression.

    Time frame: one year

  7. Reoperation Rate

    Comparing Reoperation Rate between groups

    Time frame: one year

  8. Any difference in Patient reported outcomes scores anxiety

    Patient Reported outcome scores anxiety scores are reported on a T-score scale that ranges from 7 - 35, with higher scores indicating greater anxiety.

    Time frame: one year

  9. Infection Rate (Superficial and Deep)

    Comparing Infection Rate (Superficial and Deep) between group

    Time frame: one year

  10. Amputation Ratee

    Comparing Amputation Rate between groups

    Time frame: one year

  11. Knee & ankle Range of Motion

    Comparing Knee \& ankle Range of Motion between groups

    Time frame: one year

  12. Diabetes

    Comparing diabetes between subjects and return to OR timelines

    Time frame: one year

  13. BMI

    Comparing BMI in subjects and and return to OR timelines

    Time frame: one year

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Whittle AP, Wester W, Russell TA. Fatigue failure in small diameter tibial nails. Clin Orthop Relat Res. 1995 Jun;(315):119-28. PubMed 7634660 ↗
  • Hutson JJ, Zych GA, Cole JD, Johnson KD, Ostermann P, Milne EL, Latta L. Mechanical failures of intramedullary tibial nails applied without reaming. Clin Orthop Relat Res. 1995 Jun;(315):129-37. PubMed 7634661 ↗
  • Bonafede M, Espindle D, Bower AG. The direct and indirect costs of long bone fractures in a working age US population. J Med Econ. 2013;16(1):169-78. doi: 10.3111/13696998.2012.737391. Epub 2012 Oct 22. PubMed 23035626 ↗
  • Weber CD, Hildebrand F, Kobbe P, Lefering R, Sellei RM, Pape HC; TraumaRegister DGU. Epidemiology of open tibia fractures in a population-based database: update on current risk factors and clinical implications. Eur J Trauma Emerg Surg. 2019 Jun;45(3):445-453. doi: 10.1007/s00068-018-0916-9. Epub 2018 Feb 2. PubMed 29396757 ↗
  • Park S, Ahn J, Gee AO, Kuntz AF, Esterhai JL. Compartment syndrome in tibial fractures. J Orthop Trauma. 2009 Aug;23(7):514-8. doi: 10.1097/BOT.0b013e3181a2815a. PubMed 19633461 ↗
  • Zura R, Xiong Z, Einhorn T, Watson JT, Ostrum RF, Prayson MJ, Della Rocca GJ, Mehta S, McKinley T, Wang Z, Steen RG. Epidemiology of Fracture Nonunion in 18 Human Bones. JAMA Surg. 2016 Nov 16;151(11):e162775. doi: 10.1001/jamasurg.2016.2775. Epub 2016 Nov 16. PubMed 27603155 ↗
  • Sprague S, Bhandari M. An economic evaluation of early versus delayed operative treatment in patients with closed tibial shaft fractures. Arch Orthop Trauma Surg. 2002 Jul;122(6):315-23. doi: 10.1007/s00402-001-0358-3. Epub 2001 Dec 12. PubMed 12136294 ↗
  • Anandasivam NS, Russo GS, Swallow MS, Basques BA, Samuel AM, Ondeck NT, Chung SH, Fischer JM, Bohl DD, Grauer JN. Tibial shaft fracture: A large-scale study defining the injured population and associated injuries. J Clin Orthop Trauma. 2017 Jul-Sep;8(3):225-231. doi: 10.1016/j.jcot.2017.07.012. Epub 2017 Jul 24. PubMed 28951639 ↗
  • Rosa N, Marta M, Vaz M, Tavares SMO, Simoes R, Magalhaes FD, Marques AT. Intramedullary nailing biomechanics: Evolution and challenges. Proc Inst Mech Eng H. 2019 Mar;233(3):295-308. doi: 10.1177/0954411919827044. PubMed 30887900 ↗
  • Eveleigh RJ. A review of biomechanical studies of intramedullary nails. Med Eng Phys. 1995 Jul;17(5):323-31. doi: 10.1016/1350-4533(95)97311-c. PubMed 7670691 ↗
  • Donegan DJ, Akinleye S, Taylor RM, Baldwin K, Mehta S. Intramedullary Nailing of Tibial Shaft Fractures: Size Matters. J Orthop Trauma. 2016 Jul;30(7):377-80. doi: 10.1097/BOT.0000000000000555. PubMed 26825491 ↗

Individual participant data

Plan to share: No — No plan to share individual participant data

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Dec 2029, 53 months after the start.

Of 39 interventional studies with no phase under Tibial Fractures, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 80. This study's planned 53 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 13, 2025
First posted
May 16, 2025
StartActual
Jul 1, 2025
Primary completionEst.
Dec 2029
CompletionEst.
Dec 2030
Last update
Jul 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06976801
Responsible party
Sponsor
First posted
May 16, 2025
Start date
Jul 1, 2025
Primary completion
Dec 2029 (estimated)
Completion
Dec 2030 (estimated)
Last update
Jul 9, 2026

Study contacts

Brianna Fram, MD
Contact
bfram@uchicago.edu
773-834-3531

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion